[RECALL ALERT] Cancer Agent Found in Diabetes Drug!
All drugs come with possible side effects.
Usually they’re caused by the way the drug was designed to work.
For example, heartburn drugs “work” by reducing stomach acid. But your body needs stomach acid, and you’ll experience negative effects if you suppress it (especially if you do so over a long time).
But over the past few months, numerous drugs have been pulled from the shelves because of a different problem:
They contain high levels of a contaminant that can cause cancer.
The latest drug to join the recall is one prescribed to more than 120 million diabetics worldwide.
Over the past few months, numerous drugs have been recalled because they’ve been found to contain unacceptably high levels of NDMA, a toxin listed as a possible human carcinogen.
These drugs include some of the most widely used drugs in the world, like those for blood pressure and heartburn.
Now, NDMA has mysteriously made its way into a popular medication: the diabetes drug metformin.
The FDA found that these tablets had higher than the “acceptable daily amount” of NDMA (defined as 96 nanograms per day)
They didn’t reveal exactly how much of this cancer-inducer it found, but it was high enough to warrant an immediate recall.
And it wasn’t the first time.
Earlier in the year, additional pharmaceutical companies were also forced to recall their extended-release metformin for the same problem.
I doubt the issue will be resolved anytime soon since no one seems to know where all the NDMA is coming from.
The latest recall applies to metformin tablets sold under the brand name Time-Cap Labs, Inc. It includes the following tablets:
Metformin Hydrochloride Extended-Release Tablets, USP 500mg:
- 90 counts
- 100 counts
- 500 counts
- 1000 counts
Metformin Hydrochloride Extended-Release Tablets, USP 750mg:
- 100 counts
Please check to see if you’re impacted by this recall—and talk to your doctor immediately if you are.
